JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M801045200 on April 7, 2008

J. Biol. Chem., Vol. 283, Issue 24, 16743-16751, June 13, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
283/24/16743    most recent
M801045200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Makanji, Y.
Right arrow Articles by Harrison, C. A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Makanji, Y.
Right arrow Articles by Harrison, C. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Suppression of Inhibin A Biological Activity by Alterations in the Binding Site for Betaglycan*

Yogeshwar Makanji{ddagger}§, Kelly L. Walton{ddagger}, Matthew C. Wilce, Karen L. Chan{ddagger}, David M. Robertson{ddagger}, and Craig A. Harrison{ddagger}1

From the {ddagger}Prince Henry's Institute of Medical Research, Clayton, Victoria 3168, Australia and the Departments of §Obstetrics and Gynecology and Biochemistry and Molecular Biology, Monash University, Clayton, Victoria 3168, Australia

Inhibins A and B negatively regulate the production and secretion of follicle-stimulating hormone from the anterior pituitary, control ovarian follicle development and steroidogenesis, and act as tumor suppressors in the gonads. Inhibins regulate these reproductive events by forming high affinity complexes with betaglycan and activin or bone morphogenetic protein type II receptors. In this study, the binding site of inhibin A for betaglycan was characterized using inhibin A mutant proteins. An epitope for high affinity betaglycan binding was detected spanning the outer convex surface of the inhibin {alpha}-subunit. Homology modeling indicates that key {alpha}-subunit residues (Tyr50, Val108, Thr111, Ser112, Phe118, Lys119, and Tyr120) form a contiguous epitope in this region of the molecule. Disruption of betaglycan binding by the simultaneous substitution of Thr111, Ser112, and Tyr120 to alanine yielded an inhibin A variant that was unable to suppress activin-induced follicle-stimulating hormone release by rat pituitary cells in culture. Together these results indicate that a high affinity interaction between betaglycan and residues Val108–Tyr120 of the inhibin {alpha}-subunit mediate inhibin A biological activity.


Received for publication, February 8, 2008 , and in revised form, April 3, 2008.

* This work was supported by a Monash Postgraduate Scholarship (to Y. M.) and Project CH 388920 and Program Grant DMR 241000 from the National Health and Medical Research Council of Australia. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 To whom correspondence should be addressed: Prince Henry's Institute of Medical Research, 246 Clayton Rd., Clayton, VIC 3168, Australia. Tel.: 61-3-95947915; Fax: 61-3-95947909; E-mail: craig.harrison{at}princehenrys.org.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.